B. SOW_CellMosaic.pdf
PDF 173 KB Posted
- Solicitation number
- 75N95024Q00502
About this file
This document is a Statement of Work (SOW) for the synthesis of 100 grams of the less active enantiomer '961 for the National Center for Advancing Translational Sciences (NCATS), a part of the National Institutes of Health (NIH). The objective is to provide this compound as a control for efficacy, pharmaceutics, and toxicity studies of the lead inhibitor '960. The contract has a 12-month period of performance and requires the contractor to independently deliver the 100 grams of '961 with over 99% purity. NCATS will provide existing protocols for the synthesis. The contractor shall not publish any information without NCATS approval, and all information is confidential.
The related federal contract opportunity is a pre-solicitation notice for a sole-source contract to synthesize the 100 grams of '961. The intended source is Cell Mosaic, as they are the only vendor that can provide this material. The contract will be awarded under simplified acquisition procedures, and interested parties may submit capability statements in response to the notice. The contract has a 12-month period of performance, and the award will be based on the vendor's ability to meet the requirement.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Amendment 2.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs
STATEMENT OF WORK (SOW)
GENERAL INFORMATION
Title of Project:
Synthesis of ‘961 for National Center for Advancing Translational Sciences (NCATS), Early Translation
Branch (ETB)
Statement of Need and Purpose:
NCATS is in need of a large quantity of the less active enantiomer (‘961) of lead NNMT inhibitor ‘960 for animal studies.
Background Information and Objective:
The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary
Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people’s health and save lives.
The National Center for Advancing Translational Sciences (NCATS) is a part of the National Institutes of
Health (NIH), whose mission it is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.
The Early Translation Branch aims to uncover new small-molecule probes for disease targets and advance the process of therapeutic development through a collaborative research model. Its teams have expertise in assay biology, high-throughput screening, medicinal chemistry, cheminformatics and data science to complement the disease-area expertise of external collaborators.
The lead inhibitor ‘960 from the NNMT program is being evaluated in multiple efficacy, pharmaceutics and toxicity studies with a constant need for more materials. This contract will help synthesize 100 g of
‘961, the less active enantiomer of ‘960, for use as a control in all studies.
Period of Performance:
12 months ARO.
SCOPE OF WORK
General Requirements:
Independently and not as an agent of the Government, the Contractor shall furnish all the necessary services, qualified personnel, material, equipment, and facilities, not otherwise provided by the
Government as needed to perform the Statement of Work below:
Specific Requirements:
- Delivery of 100 g of ‘961 with QC indicating >99% purity.
- 100 g of final product by weight and supplied in one bottle.
LEVEL OF EFFORT:
Scientist and/or technician with experience in compound synthesis.
GOVERNMENT RESPONSIBILITIES
NCATS will share existing protocols for the synthesis that has been executed in 4-5 g scale.
DELIVERY OR DELIVERABLES
Delivery of 100 g of ‘961 with QC indicating >99% purity.
REPORTING REQUIREMENTS
periodic progress reports in monthly and ad hoc meetings and email.
OTHER CONSIDERATIONS
Travel:
N/A
Key Personnel:
Information System Security Plan:
Data Rights:
FAR 52.227-17, Rights in Data- Special Works
Section 508—Electronic and Information Technology Standards:
Publications and Publicity:
Contractor shall not publish any information without informing NCATS. All information is confidential and NCATS will solely determine date for publication or publicity or patenting.
Confidentiality of Information:
All information shared between NCATS and contractor is confidential. The time or method for publication will be determined by NCATS.
File details come from the government source that posted it. Updated .